MBNL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.965420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.468200E-01
Normal-vs-Stage2
2.216000E-01
Normal-vs-Stage3
3.956600E-01
Normal-vs-Stage4
7.183200E-01
Stage1-vs-Stage2
8.587600E-01
Stage1-vs-Stage3
2.304800E-01
Stage1-vs-Stage4
1.338210E-01
Stage2-vs-Stage3
4.086200E-01
Stage2-vs-Stage4
2.097600E-02
Stage3-vs-Stage4
1.144230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.607220E-01
Normal-vs-AfricanAmerican
9.030400E-01
Normal-vs-Asian
3.259600E-01
Caucasian-vs-AfricanAmerican
8.967900E-02
Caucasian-vs-Asian
6.032000E-01
AfricanAmerican-vs-Asian
2.037400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.234600E-01
Normal-vs-Female
3.123600E-01
Male-vs-Female
4.109400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.965400E-01
Normal-vs-Age(41-60Yrs)
4.644600E-01
Normal-vs-Age(61-80Yrs)
5.133200E-01
Normal-vs-Age(81-100Yrs)
4.794000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.903000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.618600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.596600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.323570E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.484650E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.266600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.361000E-01
Normal-vs-Daily Drinker
1.411560E-01
Normal-vs-Weekly Drinker
1.876570E-01
Normal-vs-Occasional Drinker
3.415000E-01
Normal-vs-Social Drinker
3.103400E-01
Non Drinker-vs-Daily Drinker
3.967600E-01
Non Drinker-vs-Weekly Drinker
5.154000E-01
Non Drinker-vs-Occasional Drinker
6.290600E-01
Non Drinker-vs-Social Drinker
8.883000E-01
Daily Drinker-vs-Weekly Drinker
9.293200E-01
Daily Drinker-vs-Occasional Drinker
2.633200E-01
Daily Drinker-vs-Social Drinker
4.354600E-01
Weekly Drinker-vs-Occasional Drinker
3.574200E-01
Weekly Drinker-vs-Social Drinker
5.321600E-01
Occasional Drinker-vs-Social Drinker
7.936800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.345600E-01
Normal-vs-Grade 2
1.272380E-01
Normal-vs-Grade 3
9.870500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.614200E-01
Grade 1-vs-Grade 3
2.080800E-01
Grade 1-vs-Grade 4
2.345600E-01
Grade 2-vs-Grade 3
7.754200E-01
Grade 2-vs-Grade 4
1.272380E-01
Grade 3-vs-Grade 4
9.870500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.999600E-01
Normal-vs-NonDiabetic
4.941400E-01
Diabetic-vs-NonDiabetic
9.511200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.342400E-01
Normal-vs-NoPancreatitis
5.149000E-01
Pancreatitis-vs-NoPancreatitis
4.422000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.096000E-01
Normal-vs-N1
2.323200E-01
N0-vs-N1
5.468800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.757400E-01
Normal-vs-TP53-NonMutant
3.940600E-01
TP53-Mutant-vs-TP53-NonMutant
9.930000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
